{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:53Z","timestamp":1790775773147,"version":"4.1.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0132978","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T18:12:30Z","timestamp":1438279950000},"page":"e0132978","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["The Crosstalk between Nrf2 and TGF-\u03b21 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells"],"prefix":"10.1371","volume":"10","author":[{"given":"Sarah","family":"Arfmann-Kn\u00fcbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeske","family":"Genrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Sebens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","article-title":"Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition","volume":"21","author":"CH Heldin","year":"2009","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4161\/cc.11.4.19130","article-title":"The emerging role of the TGF\u03b2 tumor suppressor pathway in pancreatic cancer","volume":"11","author":"DJ Birnbaum","year":"2012","journal-title":"Cell Cycle"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/path.2785","article-title":"The dynamic roles of TGF-\u03b2 in cancer","volume":"223","author":"E Meulmeester","year":"2011","journal-title":"J Pathol"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc3278","article-title":"NRF2 and cancer: the good, the bad and the importance of context","volume":"12","author":"MB Sporn","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.freeradbiomed.2013.06.041","article-title":"Oncogenic functions of the transcription factor Nrf2","volume":"65","author":"I Ganan-Gomez","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1096\/fj.12-217257","article-title":"The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?","volume":"27","author":"P Shelton","year":"2013","journal-title":"FASEB J"},{"key":"ref7","first-page":"1497","article-title":"Cytoproection gone astray: the role of Nrf2 in cancer","volume":"7","author":"C Geismann","year":"2014","journal-title":"Oncol Target Ther"},{"key":"ref8","article-title":"The dual roles of Nrf2 in tumor prevention and progression: possile implications in cancer treatment","author":"EJ Moon","year":"2014","journal-title":"Free Radic Biol.Med"},{"issue":"1\u20132","key":"ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrrev.2007.11.006","article-title":"Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults","volume":"659","author":"WO Osburn","year":"2008","journal-title":"Mutat Res"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"JW Kaspar","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/ars.2010.3221","article-title":"Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway","volume":"13","author":"JD Hayes","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","article-title":"Toward clinical application of the Keap1-Nrf2 pathway","volume":"34","author":"T Suzuki","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"5\u20136","key":"ref13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.phrs.2008.09.003","article-title":"Dual roles of Nrf2 in cancer","volume":"58","author":"A Lau","year":"2008","journal-title":"Pharmacol Res"},{"issue":"20","key":"ref14","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2-Keap1 signaling pathway in cancer","volume":"27","author":"MC Jaramillo","year":"2013","journal-title":"Genes Dev"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and-independent mechanisms of regulation","volume":"85","author":"HK Bryan","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"S Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"7354","key":"ref17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"GM DeNicola","year":"2011","journal-title":"Nature"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1089\/ars.2010.3219","article-title":"Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance","volume":"13","author":"A Singh","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.critrevonc.2013.09.001","article-title":"Nrf2 is a potential therapeutic target in radioresistance in human cancer","volume":"88","author":"S Zhou","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.15430\/JCP.2014.19.2.111","article-title":"Targeting nrf2 signaling to combat chemoresistance","volume":"19","author":"JH No","year":"2014","journal-title":"J Cancer Prev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-4598-10-37","article-title":"Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy","volume":"10","author":"A Lister","year":"2011","journal-title":"Mol Cancer"},{"issue":"45","key":"ref22","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/onc.2011.628","article-title":"Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers","volume":"31","author":"T Yamadori","year":"2012","journal-title":"Oncogene"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/neuonc\/nos262","article-title":"Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells","volume":"14","author":"DY Lu","year":"2012","journal-title":"Neuro Oncol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/dote.12124","article-title":"Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment","volume":"27","author":"H Shen","year":"2014","journal-title":"Dis Esophagus"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-10-3007","article-title":"NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1\u03b1","volume":"71","author":"TH Kim","year":"2011","journal-title":"Cancer Res"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ijc.28699","article-title":"Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha","volume":"135","author":"X Ji","year":"2014","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Y Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"JD Hayes","year":"2014","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1200\/JCO.2005.02.047","article-title":"Role of transforming growth factor Beta in human cancer","volume":"23","author":"RL Elliott","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.prp.2013.10.001","article-title":"Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma","volume":"210","author":"Y Soini","year":"2014","journal-title":"Pathol Res Pract"},{"issue":"1\u20132","key":"ref31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.09.003","article-title":"Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease","volume":"17","author":"SG Rane","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2174\/138920111798808356","article-title":"Oettle H Transforming growth factor beta in pancreatic cancer","volume":"12","author":"A Hilbig","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"40","key":"ref33","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1038\/onc.2012.493","article-title":"Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity","volume":"32","author":"A Arlt","year":"2013","journal-title":"Oncogene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPA.0b013e3181c31314","article-title":"Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells","volume":"39","author":"YB Hong","year":"2010","journal-title":"Pancreas"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1158\/0008-5472.CAN-08-3493","article-title":"Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer","volume":"69","author":"C Geismann","year":"2009","journal-title":"Cancer Res"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3109\/10715762.2010.507670","article-title":"Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases","volume":"44","author":"S Singh","year":"2010","journal-title":"Free Radic Res"},{"key":"ref37","first-page":"149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","author":"G Landskron","year":"2014","journal-title":"J Immunol Res"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.freeradbiomed.2004.10.033","article-title":"Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins","volume":"38","author":"AV Bakin","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"28","key":"ref39","doi-asserted-by":"crossref","first-page":"20658","DOI":"10.1074\/jbc.M113.450478","article-title":"Transforming growth factor-beta induces transcription factors MafK and Bach1 to suppress expression of the heme oxygenase-1 gene","volume":"288","author":"Y Okita","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.taap.2009.07.030","article-title":"Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression","volume":"240","author":"HK Choi","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"e45870","DOI":"10.1371\/journal.pone.0045870","article-title":"Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta\/Smad signaling","volume":"7","author":"CJ Oh","year":"2012","journal-title":"PLoS One"},{"issue":"25","key":"ref42","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1038\/onc.2010.118","article-title":"Increased cell migration and plasticity in Nrf2-deficient cancer cell lines","volume":"29","author":"G Rachakonda","year":"2010","journal-title":"Oncogene"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1756-9966-31-66","article-title":"Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2","volume":"31","author":"L Zhang","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"issue":"3\u20134","key":"ref44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.wneu.2011.06.063","article-title":"The role of Nrf2 in migration and invasion of human glioma cell U251","volume":"80","author":"H Pan","year":"2013","journal-title":"World Neurosurg"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1242\/jcs.095422","article-title":"E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells","volume":"125","author":"WD Kim","year":"2012","journal-title":"J Cell Sci"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1091\/mbc.E12-09-0666","article-title":"Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence","volume":"24","author":"D Volonte","year":"2013","journal-title":"Mol Biol Cell"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0002-9440(10)65567-8","article-title":"Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma","volume":"153","author":"N Liu","year":"1998","journal-title":"Am J Pathol"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0022-4804(90)90145-R","article-title":"Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma","volume":"48","author":"MP Vezeridis","year":"1990","journal-title":"J Surg Res"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/0008-5472.CAN-04-1626","article-title":"Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells","volume":"65","author":"S M\u00fcerk\u00f6ster","year":"2005","journal-title":"Cancer Res"},{"issue":"20","key":"ref50","first-page":"4592","article-title":"Dpc4 transcriptional activation and dysfunction in cancer cells","volume":"58","author":"JL Dai","year":"1998","journal-title":"Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/sj.onc.1210076","article-title":"Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells","volume":"26","author":"M\u00fcerk\u00f6ster S Sebens","year":"2007","journal-title":"Oncogene"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"e94357","DOI":"10.1371\/journal.pone.0094357","article-title":"Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma","volume":"9","author":"O Helm","year":"2014","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0960-7404(02)00015-4","article-title":"Inflammation and the development of pancreatic cancer","volume":"10","author":"B Farrow","year":"2002","journal-title":"Surg. Oncol."},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijc.22871","article-title":"Pancreatic cancer microenvironment","volume":"121","author":"J Kleeff","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"H Kurahara","year":"2011","journal-title":"J Surg Res"},{"issue":"18","key":"ref56","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","article-title":"Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions","volume":"12","author":"N Hiraoka","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ijc.23703","article-title":"Role of myofibroblasts on innate chemoresistance in pancreatic carcinoma\u2013epigenetic down-regulation of caspases","volume":"123","author":"SS M\u00fcerk\u00f6ster","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"47","key":"ref58","doi-asserted-by":"crossref","first-page":"40911","DOI":"10.1074\/jbc.M111.274902","article-title":"Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection","volume":"286","author":"S Sebens","year":"2011","journal-title":"J Biol Chem"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00428-003-0784-4","article-title":"A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform","volume":"442","author":"B Sipos","year":"2003","journal-title":"Virchows Arch"},{"issue":"9","key":"ref60","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/modpathol.2011.74","article-title":"Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas","volume":"24","author":"SM Hong","year":"2011","journal-title":"Mod Pathol"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000055903","article-title":"Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma","volume":"2","author":"YE Joo","year":"2002","journal-title":"Pancreatology"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1711740403","article-title":"Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage","volume":"174","author":"M Pignatelli","year":"1994","journal-title":"J Pathol"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"e1000083","DOI":"10.1080\/2162402X.2014.1000083","article-title":"CD4+ T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells\u2014novel implications of CD4+ T cells in pancreatic cancer development","volume":"4","author":"L Goebel","year":"2015","journal-title":"OncoImmunology"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.1014275108","article-title":"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism","volume":"108","author":"D Ren","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/ijo.2013.2229","article-title":"Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine","volume":"44","author":"HQ Duong","year":"2014","journal-title":"Int J Oncol"},{"issue":"4","key":"ref66","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2014.04.039","article-title":"Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo","volume":"447","author":"S Chian","year":"2014","journal-title":"Biochem Biophys Res Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0132978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T18:08:12Z","timestamp":1599415692000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0132978"}},"subtitle":[],"editor":[{"given":"Hidayatullah G","family":"Munshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":66,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0132978","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}